Letter to the Editor: Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration
Journal of Ocular Pharmacology and Therapeutics · 2024
DOI: 10.1089/jop.2024.0013 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Ocular Pharmacology and Therapeutics, 2024. Verfasst von Michael Colucciello. Beteiligte Einrichtung: Clinical Associate, University of Pennsylvania School of Medicine, Philadelphia, PA, USA. Hauptthemen laut MEDLINE: Macular Degeneration, Wet Macular Degeneration. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 4 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Clinical Associate, University of Pennsylvania School of Medicine, Philadelphia, PA, USA.
- Retina Department, Prism Vision Group-South Jersey Eye Physicians Division, Moorestown, New Jersey, USA.
ORCID-Profile: Michael Colucciello
Zitieren
APA
Colucciello, M. (2024). Letter to the Editor: Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. https://doi.org/10.1089/jop.2024.0013
Vancouver
Colucciello M. Letter to the Editor: Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration. Journal of Ocular Pharmacology and Therapeutics. 2024. doi:10.1089/jop.2024.0013
BibTeX
@article{Colucciello2024,
author = {Colucciello, Michael},
title = {Letter to the Editor: Steroid/AntiVascular Endothelial Growth Factor Combination Therapy for Neovascular Age-Related Macular Degeneration},
journal = {Journal of Ocular Pharmacology and Therapeutics},
year = {2024},
doi = {10.1089/jop.2024.0013}
}
EUVIMED